GlaxoSmithKline Consumer Healthcare Ltd. - Research Center
500676 GSKCONS Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 19 | Mar ' 18 | Mar ' 17 | Mar ' 16 | Mar ' 15 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 4,782.01 | 4,316.52 | 3,986.46 | 4,308.73 | 4,307.59 |
| Expenses | |||||
| Material consumed | 1,442.60 | 1,437.79 | 1,302.67 | 1,349.32 | 1,505.07 |
| Manufacturing expenses | 76.79 | 73.43 | 72.31 | 78.66 | 80.86 |
| Personnel expenses | 644.62 | 527.73 | 458.03 | 509.40 | 431.29 |
| Selling expenses | 602.25 | 546.73 | 514.67 | 544.09 | - |
| Adminstrative expenses | 874.77 | 847.48 | 805.29 | 992.38 | 1,560.28 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 3,641.04 | 3,433.16 | 3,152.97 | 3,473.84 | 3,577.50 |
| Operating profit | 1,140.97 | 883.36 | 833.49 | 834.88 | 730.08 |
| Other recurring income | 432.60 | 257.41 | 243.88 | 278.74 | 221.89 |
| Adjusted PBDIT | 1,573.57 | 1,140.76 | 1,077.37 | 1,113.63 | 951.97 |
| Financial expenses | 0.78 | 2.03 | 2.78 | 0.79 | 0.74 |
| Depreciation | 60.50 | 64.37 | 64.18 | 57.44 | 62.09 |
| Other write offs | - | - | - | - | - |
| Adjusted PBT | 1,512.29 | 1,074.36 | 1,010.42 | 1,055.40 | 889.14 |
| Tax charges | 529.49 | 374.26 | 353.74 | 368.48 | 305.54 |
| Adjusted PAT | 982.80 | 700.10 | 656.68 | 686.91 | 583.60 |
| Non recurring items | 7.04 | 16.67 | - | - | - |
| Other non cash adjustments | - | - | - | - | - |
| Reported net profit | 989.85 | 716.77 | 656.68 | 686.91 | 583.60 |
| Earnigs before appropriation | 3,387.10 | 2,751.57 | 2,367.52 | 1,780.78 | 1,430.62 |
| Equity dividend | 250.58 | 234.46 | 234.46 | 234.46 | 184.22 |
| Preference dividend | - | - | - | - | - |
| Dividend tax | 64.83 | 59.93 | 59.93 | 59.93 | 47.09 |
| Retained earnings | 3,071.68 | 2,457.19 | 2,073.13 | 1,486.39 | 1,199.31 |
Mutual Fund Selector
Find the fund that is right for you
© 2022 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis